| Summary: | Our previous work identified isoxazole-based chalcones and their dihydropyrazole derivatives as two important five-membered heterocycles having antitubercular activity. Hence, in the present study, we biologically evaluated 30 compounds, including 15 isoxazole ring-containing chalcones (<b>17</b>−<b>31</b>) and 15 dihydropyrazoles (<b>32</b>−<b>46</b>) derived from these chalcones for their antimicrobial, antioxidant, and anticancer activities. Chalcones exhibited superior antibacterial and antioxidant activities compared to dihydropyrazoles. Among the chalcones, compound <b>28</b> showed potent antibacterial (MIC = 1 µg/mL) and antioxidant activities (IC<sub>50</sub> = 5 ± 1 µg/mL). Dihydropyrazoles, on the contrary, demonstrated remarkable antifungal and anticancer activities. Compound <b>46</b> (IC<sub>50</sub> = 2 ± 1 µg/mL) showed excellent antifungal activity whereas two other dihydropyrazoles <b>45</b> (IC<sub>50</sub> = 2 ± 1 µg/mL) and <b>39</b> (IC<sub>50</sub> = 4 ± 1 µg/mL) exhibited potential anticancer activity. The compounds were also tested for their toxicity on normal human cell lines (LO2) and were found to be nontoxic. The active compounds that have emerged out of this study are potential lead molecules for the development of novel drugs against infectious diseases, oxidative stress, and cancer.
|
|---|
